Nanosphere Will Submit Troponin Assay to FDA This Year, Expand European Launch
May 03, 2011
Nanosphere Will Submit Troponin Assay to FDA This Year, Expand European Launch
Nanosphere said it has completed data collection in a fast track trial toward submitting its cardiac troponin I assay for FDA approval later this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.